ā† Back to Search

Behavioral Intervention

Cognitive Bias Modification - Interpretation training for Anxiety

Phase 2
Recruiting
Led By Bethany Teachman, PhD
Research Sponsored by University of Virginia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, and after sessions 1,2, 3, 4, 5 (sessions will be spaced ~1 week apart) & at 2-month follow-up (~2 months after session 5). session 1 occurs ~0-7 days after baseline. measure will be completed immediately following that day's training session.
Awards & highlights

Summary

This trial will compare two methods of delivering cognitive behavioral therapy for insomnia (CBT-I) - via computer or mobile phone - to see which is more effective. They will also test if adding minimal human contact for participants at risk of dropout improves retention and outcomes.

Eligible Conditions
  • Anxiety

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, and after sessions 1,2, 3, 4, 5 (sessions will be spaced ~1 week apart) & at 2-month follow-up (~2 months after session 5). session 1 occurs ~0-7 days after baseline. measure will be completed immediately following that day's training session.
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, and after sessions 1,2, 3, 4, 5 (sessions will be spaced ~1 week apart) & at 2-month follow-up (~2 months after session 5). session 1 occurs ~0-7 days after baseline. measure will be completed immediately following that day's training session. for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in Brief Bodily Sensations Interpretations Questionnaire
Change in Depression, Anxiety, Stress Scales-Short Form: Anxiety Subscale
Change in Overall Anxiety Severity and Impairment Scale
+1 more
Secondary study objectives
Change in Alcohol Use Comorbid symptoms
Anxiety
Comorbidity
+8 more

Trial Design

4Treatment groups
Experimental Treatment
Active Control
Group I: CBM-I, low attritionExperimental Treatment1 Intervention
Computer- or phone-based Cognitive Bias Modification - Interpretation training
Group II: CBM-I, high attrition, no coachExperimental Treatment1 Intervention
Computer- or phone-based Cognitive Bias Modification - Interpretation training
Group III: CBM-I, high attrition, coachExperimental Treatment2 Interventions
Computer- or phone-based Cognitive Bias Modification - Interpretation training + Coaching
Group IV: PsychoeducationActive Control1 Intervention
Online psychoeducation about anxiety
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Coaching
2016
Completed Phase 3
~5600

Find a Location

Who is running the clinical trial?

University of VirginiaLead Sponsor
771 Previous Clinical Trials
1,283,457 Total Patients Enrolled
4 Trials studying Anxiety
1,314 Patients Enrolled for Anxiety
Bethany Teachman, PhDPrincipal InvestigatorUniv. of Virginia
1 Previous Clinical Trials
233 Total Patients Enrolled
1 Trials studying Anxiety
233 Patients Enrolled for Anxiety
~128 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top